tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

DE:BM8 Stock Latest News

Viridian Therapeutics appoints Ajer to its board of directors
The FlyViridian Therapeutics appoints Ajer to its board of directors
13h ago
BMRN
VRDN
BioMarin Pharmaceutical: Hold Rating Amid Promising Trial Results and Safety Concerns
PremiumRatings
BioMarin Pharmaceutical: Hold Rating Amid Promising Trial Results and Safety Concerns
5d ago
BMRN
BioMarin Pharmaceutical: Promising Growth Driven by Palynziq Success and Pipeline Opportunities
PremiumRatings
BioMarin Pharmaceutical: Promising Growth Driven by Palynziq Success and Pipeline Opportunities
5d ago
BMRN
BioMarin: Phase 3 PEGASUS trial of Palynziq met primary endpoint
PremiumThe Fly
BioMarin: Phase 3 PEGASUS trial of Palynziq met primary endpoint
5d ago
BMRN
BioMarin presents studies showing efficacy of Voxzogo, Palynziq
PremiumThe Fly
BioMarin presents studies showing efficacy of Voxzogo, Palynziq
18d ago
BMRN
Strong Growth Potential and Strategic Positioning Make BioMarin Pharmaceutical a Buy Recommendation
PremiumRatingsStrong Growth Potential and Strategic Positioning Make BioMarin Pharmaceutical a Buy Recommendation
29d ago
BMRN
BioMarin Pharmaceutical: Strategic Growth and Pipeline Potential Drive Buy Rating
Premium
Ratings
BioMarin Pharmaceutical: Strategic Growth and Pipeline Potential Drive Buy Rating
1M ago
BMRN
BioMarin Expands Board with New Independent Director
Premium
Company Announcements
BioMarin Expands Board with New Independent Director
1M ago
8K
BMRN
Alibaba upgraded, Rivian downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Alibaba upgraded, Rivian downgraded: Wall Street’s top analyst calls
1M ago
BYD
CAG
BioMarin upgraded to Outperform from Perform at Oppenheimer
PremiumThe Fly
BioMarin upgraded to Outperform from Perform at Oppenheimer
1M ago
BMRN
Oppenheimer upgrades BioMarin with stage set for increasing interest
PremiumThe Fly
Oppenheimer upgrades BioMarin with stage set for increasing interest
1M ago
BMRN
Strong Growth Potential and Strategic Initiatives Drive BioMarin Pharmaceutical’s Outperform Rating
PremiumRatings
Strong Growth Potential and Strategic Initiatives Drive BioMarin Pharmaceutical’s Outperform Rating
1M ago
BMRN
BioMarin Pharmaceutical: Strong Q4 Performance, Future Growth Prospects, and Ongoing Challenges Justify Hold Rating
PremiumRatingsBioMarin Pharmaceutical: Strong Q4 Performance, Future Growth Prospects, and Ongoing Challenges Justify Hold Rating
2M ago
BMRN
BioMarin Pharmaceutical: Buy Rating Affirmed on Strong Growth Prospects and Strategic Developments
Premium
Ratings
BioMarin Pharmaceutical: Buy Rating Affirmed on Strong Growth Prospects and Strategic Developments
2M ago
BMRN
BioMarin’s Earnings Call Highlights Strong Growth and Optimism
Premium
Company Announcements
BioMarin’s Earnings Call Highlights Strong Growth and Optimism
2M ago
BMRN
BioMarin Pharmaceutical: Strong Growth Prospects with Strategic Initiatives Justifying Buy Rating
PremiumRatings
BioMarin Pharmaceutical: Strong Growth Prospects with Strategic Initiatives Justifying Buy Rating
2M ago
BMRN
BioMarin price target raised to $80 from $78 at Scotiabank
PremiumThe Fly
BioMarin price target raised to $80 from $78 at Scotiabank
2M ago
BMRN
BioMarin price target raised to $113 from $109 at UBS
PremiumThe Fly
BioMarin price target raised to $113 from $109 at UBS
2M ago
BMRN
BioMarin Pharmaceutical: Strong Financial Performance and Promising Growth Prospects Warrant Buy Rating
PremiumRatings
BioMarin Pharmaceutical: Strong Financial Performance and Promising Growth Prospects Warrant Buy Rating
2M ago
BMRN
BioMarin price target raised to $103 from $99 at BofA
PremiumThe FlyBioMarin price target raised to $103 from $99 at BofA
2M ago
BMRN
Strong Financial Performance and Positive Outlook for BioMarin Pharmaceutical
Premium
Ratings
Strong Financial Performance and Positive Outlook for BioMarin Pharmaceutical
2M ago
BMRN
Strong Financial Performance and Strategic Growth Drive Buy Rating for BioMarin Pharmaceutical
Premium
Ratings
Strong Financial Performance and Strategic Growth Drive Buy Rating for BioMarin Pharmaceutical
2M ago
BMRN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >